- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02912741
One Year Clinical Evaluation of White Spot Lesions Treated With Newly Introduced Resin Modified Glass Ionomer in Comparison to Resin Infiltration in Anterior Teeth Split Mouth Technique
Double Blinded Randomized Clinical Trial for Evaluation of Resin Modified Glass Ionomer Cement Versus Resin Infiltration in Treating White Spot Lesions
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Roles and responsibilities:
- Shaimaa Mohammed (SH.M.): Operator and author.Specialist in Air-Force Specialized Hospital.
- Mohamed Riad (M.R.): Main supervisor, data monitoring and auditing, Professor, Conservative Dentistry Department,Cairo University.
- Asma Harhash(A.H.):Co-supervisor, outcome assessor and data collection, Associate Professor, Russian University.
- Omnia Magdy Moustafa (O.M.): Baseline data collection, recruitment, sequence generation, allocation concealment, patient retention and taking participants consents: Assistant lecturer, Conservative Dentistry Department , Faculty of Oral and Dental Medicine Cairo University.
- Ghada Ahmed (G.A.): Data entry and auditing; Assistant lecturer, Conservative Dentistry Department, Faculty of Oral and Dental Medicine, Russian University.
Intervention:
A- Preoperative clinical assessment:
- Explain patient need toward aesthetic needs
- Digital photos for white spot lesions
Recording number of white spot lesions and site. (SH.M.) will apply both materials at the same patient mouth (Split mouth technique) according to the manufacturer's instructions.
- Intervention: resin modified glass ionomer cement varnish: Vanish™ xt Extended Contact Varnish (3M ESPE Dental)
- Comparator: resin infiltration (Dental Milestones Guaranteed, Germany).
(A.H) and (SH.M) will assess the outcome measures through the follow up time: immediately after,1 day, 1 week,1 month,3 months, 6 months, 12 months
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Post-Orthodontic patients included in this clinical trial toll age of 35 years.
- Patients with good general health.
- Patients who will agree to the consent and will commit to follow-up period.
- Fully erupted anterior teeth with no cavitated lesions.
- At least one spot lesion on each side in the same jaw
Exclusion Criteria:
- Patients with any systemic disease that may affect normal healing.
- Patient with bad oral hygiene.
- Tetracycline or fluorsis staining.
- Patients who could/would not participate in all times of follow-up.
- Untreated periodontal disease was not allowed.
- Active caries or defective Restorations in 6 anterior teeth.
- Bleaching history
- Patients participating in more than 1 dental study.
- Patient received fluoride varnish during orthodontic treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Vanish xt Extended Contact Varnish
Vanish xt Extended Contact Varnish is a resin modified glass ionomer cement and fluoride varnish used to treat white spot lesions to be more resistant to early caries progression.
|
resin modified glass- ionomer cement varnish applied as a thin layer coating and cured
Other Names:
|
|
Active Comparator: Resin infiltration
Resin infiltration is a low viscous resin infiltrates into small pores of white spot lesions to block entrance of bacteria into dentinal tubules of the tooth and more resistant to early caries progression.
|
low viscous light cure resin applied in layers and cured
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Patient satisfaction
Time Frame: immediately, 1 day, 1week,1 month,3 month,6 month and1 year
|
using visual analogue scale ruler (0-100 mm) 0 refer to not satisfied at all,100 refer to total satisfied
|
immediately, 1 day, 1week,1 month,3 month,6 month and1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in color change
Time Frame: immediately, 1 day, 1week,1 month,3 month,6 month and1 year
|
using vita easy shade device
|
immediately, 1 day, 1week,1 month,3 month,6 month and1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in caries lesion state
Time Frame: immediately, 1 day, 1week,1 month,3 month,6 month and1 year
|
Diagnodent device
|
immediately, 1 day, 1week,1 month,3 month,6 month and1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ahmed Elkhadem, PhD, Cairo University
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CEBD-CU-2016-09-209
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.